Ovarian Sertoli-Leydig cell tumors. A retrospective MITO study
- 1 June 2012
- journal article
- research article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 125 (3), 673-676
- https://doi.org/10.1016/j.ygyno.2012.03.024
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Bilateral Ovarian Well-Differentiated Sertoli-Leydig Cell Tumors With Heterologous Elements Associated With Unilateral Serous Cystadenoma–A Case ReportInternational Journal of Gynecological Pathology, 2010
- Sertoli-Leydig cell tumour in a 13-year-old girlGynecological Endocrinology, 2010
- Patterns of metastasis in sex cord-stromal tumors of the ovary: Can routine staging lymphadenectomy be omitted?Gynecologic Oncology, 2009
- Current FIGO staging for cancer of the vagina, fallopian tube, ovary, and gestational trophoblastic neoplasiaInternational Journal of Gynecology & Obstetrics, 2009
- Ovarian Sertoli‐Leydig cell tumor with heterologous gastrointestinal epithelium as a source of alpha‐fetoprotein: A case reportJournal of Obstetrics and Gynaecology Research, 2008
- Sertoli–Leydig cell tumor: A rare ovarian neoplasm. Case report and review of literatureGynecological Endocrinology, 2008
- Management of Ovarian Stromal Cell TumorsJournal of Clinical Oncology, 2007
- The activity of taxanes compared with bleomycin, etoposide, and cisplatin in the treatment of sex cord-stromal ovarian tumorsGynecologic Oncology, 2005
- Bleomycin, Etoposide, and Cisplatin Combination Therapy of Ovarian Granulosa Cell Tumors and Other Stromal Malignancies: A Gynecologic Oncology Group StudyGynecologic Oncology, 1999
- Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatinObstetrics & Gynecology, 1996